Healthium Medtech, a global medtech company that aims to provide access to precision medtech to surgeons and hospitals across various medical sectors and 70 countries, has partnered with capital markets regulator SEBI to raise funds through an initial public offering (IPO). Preliminary draft letter has been filed. As per the draft Red Herring Prospectus (DRHP), the IPO consists of an offer for sale of equity shares worth Rs 390 crore and sale of 3.91 crore equity shares by existing shareholders and promoters.
As per the regulatory filing, it reads that as a part of the offer-for-sale, Quinag Acquisition (FDI) Ltd will sell 3.9 crore equity shares and Mahadevan Narayanomani will sell 1 lakh shares. Proceeds of Rs 50.09 crore from the new issue will be used to repay debt, Rs 179.46 crore will be invested in its subsidiaries Sironics, Clinics and Kwality Needles and Rs 58 crore will be used for acquisitions and other strategic initiatives.
Company Profile: Healthium MedTech is a global medtech company focused on products used in surgical, post-surgical and chronic care. It operates in three major markets, India, the UK and the rest of the world, and in four focus areas, namely advanced surgery, urology, arthroscopy and wound care.